<unk>  is a guanylate cyclase-C agonist that is FDA approved for the {{{indicationType}}} of irritable bowel syndrome with constipation (IBS-C), chronic idiopathic constipation (CIC). There is a Black Box Warning for this drug as shown here.  Common adverse reactions include diarrhea, abdominal pain, flatulence and abdominal distension.
Linaclotide
Rotigaptide
Pramlintide
Mitiglinide
Linagliptin
Insulin degludec
Exenatide
Lixisenatide